These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30390330)

  • 21. Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis.
    Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
    Gene; 2016 Apr; 581(1):31-42. PubMed ID: 26784657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis.
    Gopal P; Yee M; Sarathy J; Low JL; Sarathy JP; Kaya F; Dartois V; Gengenbacher M; Dick T
    ACS Infect Dis; 2016 Sep; 2(9):616-626. PubMed ID: 27759369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance.
    Khan MT; Ali S; Zeb MT; Kaushik AC; Malik SI; Wei DQ
    Front Mol Biosci; 2020; 7():52. PubMed ID: 32328498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis.
    Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of pncA gene mutations W68R and W68G in pyrazinamide resistance.
    Aggarwal M; Singh A; Grover S; Pandey B; Kumari A; Grover A
    J Cell Biochem; 2018 Mar; 119(3):2567-2578. PubMed ID: 28980723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free energy landscape and thermodynamics properties of novel mutations in PncA of pyrazinamide resistance isolates of
    Tahir Khan M; Dumont E; Chaudhry AR; Wei DQ
    J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37837425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant
    Shi J; Su R; Zheng D; Zhu Y; Ma X; Wang S; Li H; Sun D
    Infect Drug Resist; 2020; 13():2929-2941. PubMed ID: 32903869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Pyrazinamide Action and Resistance.
    Zhang Y; Shi W; Zhang W; Mitchison D
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0023-2013. PubMed ID: 26104205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
    Rajendran V; Sethumadhavan R
    J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant
    Hameed HA; Tan Y; Islam MM; Lu Z; Chhotaray C; Wang S; Liu Z; Fang C; Tan S; Yew WW; Zhong N; Liu J; Zhang T
    Infect Drug Resist; 2020; 13():217-227. PubMed ID: 32158237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance.
    Khan MT; Malik SI
    J Biomol Struct Dyn; 2020 Jul; 38(10):3003-3017. PubMed ID: 31357912
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Ragunathan P; Cole M; Latka C; Aragaw WW; Hegde P; Shin J; Subramanian Manimekalai MS; Rishikesan S; Aldrich CC; Dick T; Grüber G
    ACS Chem Biol; 2021 Jun; 16(6):1030-1039. PubMed ID: 33984234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrazinamide-resistant mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa and rpsA mutations.
    Khan MT; Malik SI; Bhatti AI; Ali S; Khan AS; Zeb MT; Nadeem T; Fazal S
    J Biol Regul Homeost Agents; 2018; 32(3):705-709. PubMed ID: 29921403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery and evaluation of new compounds targeting ribosomal protein S1 in antibiotic-resistant Mycobacterium Tuberculosis.
    Dai Y; Xu Y; Guo C; Xue X; Lin D; Lin K
    Eur J Med Chem; 2020 Jun; 196():112317. PubMed ID: 32311606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
    Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
    Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural insights of catalytic mechanism in mutant pyrazinamidase of
    Junaid M; Li CD; Li J; Khan A; Ali SS; Jamal SB; Saud S; Ali A; Wei DQ
    J Biomol Struct Dyn; 2021 Jun; 39(9):3172-3185. PubMed ID: 32340563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
    Sun Z; Zhang Y
    Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.